Robert Goeltz II - Jan 23, 2024 Form 4/A Insider Report for Arcus Biosciences, Inc. (RCUS)

Role
Chief Financial Officer
Signature
/s/ Carolyn Tang, Attorney-in-Fact
Stock symbol
RCUS
Transactions as of
Jan 23, 2024
Transactions value $
$0
Form type
4/A
Date filed
2/23/2024, 05:49 PM
Date Of Original Report
Jan 25, 2024
Previous filing
Jan 4, 2024
Next filing
Dec 17, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCUS Common Stock Award $0 +22K +42.45% $0.00 73.8K Jan 23, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2024, subject to the Reporting Person's continued service to the Company.

Remarks:

This amendment is being filed to address an error in reporting the number of restricted stock units granted to Mr. Goeltz on January 23, 2024.